Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Equifax

from “neutral” to “outperform.” The target price for Equifax has been raised from $65 to $80. Equifax's shares closed at $68.45 yesterday. JP Morgan upgraded Allergan

from “neutral” to “overweight.” The target price for Allergan has been raised from $130 to $190. Allergan's shares closed at $163.65 yesterday. Analysts at Wells Fargo upgraded E*TRADE Financial

from “market perform” to “outperform.” E*TRADE Financial's shares closed at $21.65 yesterday. Morgan Stanley upgraded athenahealth

from “equal-weight” to “overweight.” The target price for athenahealth has been raised from $133 to $192. athenahealth's shares closed at $134.12 yesterday.